| 证券代码 | ABEOW.O |
| 证券名称 | Abeona Therapeutics Inc Wt |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2014-12-19 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | Abeona Therapeutics Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 3333 Lee Parkway, Suite 600, Dallas, Texas, USA |
| 成立日期 | 1974 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.abeonatherapeutics.com |
| 电话 | +1 (214) 665-9495 |
| 传真 | - |
| 公司简介 | Abeona Therapeutics Inc. (NASDAQ: ABEO) is a clinical-stage biopharmaceutical company focused on developing novel therapies for life-threatening rare genetic diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. |